Document Detail


Sexual dysfunction in patients under dialytic treatment.
MedLine Citation:
PMID:  16767073     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: Erectile dysfunction (ED) is very common in patients with renal failure, probably as a side effect of long-term treatments and dialysis, among other etiologic factors. Over the last few years, new highly effective oral treatments for ED have been introduced in the market. We designed a prospective trial in 42 dialytic patients with ED, focusing on the therapeutic effect of syldenafil and apomorphine. METHODS: Forty-two patients aged 57 years (range 34-71), [40 on hemodialysis (HD) and 2 on peritoneal dialysis (PD)] were enrolled in a prospective study comparing sildenafil with apomorphine. After a careful nephrologic anamnesis and uroandrological examination, all patients underwent, before and after each treatment, the International Index Erectile Function (IIEF) test, and the Life Satisfaction test. Expert opinion was based on grading of evidence based medical literature, widespread internal committee discussion, public presentations and debates. RESULTS: The 2 patients on PD were the only responders to 25 mg sildenafil; 25 patients on HD had a clear improvement of the IIEF score after 50 mg sildenafil administration; finally, 11 patients on HD would benefit only from 100 mg sildenafil; the nonresponders to sildenafil were only 4 patients, having to switch to PgE1. When apomorphine was tested on the same patients, a mild response was seen only in 6 patients at the 3 mg dose. No response was seen in the 2 patients on PD. CONCLUSIONS: There was a statistically significant difference in the therapeutic role of sildenafil versus apomorphine, the first producing an overall improvement of the IIEF in 90.5% of patients, compared to 14% of the same patients receiving apomorphine (P<0.001).
Authors:
G Dachille; V Pagliarulo; G M Ludovico; D Ralph; A Pagliarulo
Related Documents :
19200383 - Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemod...
20862543 - Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what...
3014953 - Activated alveolar macrophage and lymphocyte alveolitis in extrathoracic sarcoidosis wi...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  Minerva urologica e nefrologica = The Italian journal of urology and nephrology     Volume:  58     ISSN:  0393-2249     ISO Abbreviation:  Minerva Urol Nefrol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-06-12     Completed Date:  2006-08-30     Revised Date:  2008-06-23    
Medline Journal Info:
Nlm Unique ID:  8503649     Medline TA:  Minerva Urol Nefrol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  195-200     Citation Subset:  IM    
Affiliation:
Unit of Emergency Medicine and Organ Transplantation, Department of Urology, Polyclinic of Bari, Bari, Italy. gdach72@libero.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Apomorphine / therapeutic use*
Erectile Dysfunction / drug therapy*,  etiology*
Humans
Male
Middle Aged
Phosphodiesterase Inhibitors / therapeutic use*
Piperazines / therapeutic use*
Prospective Studies
Purines
Renal Dialysis / adverse effects*
Sulfones
Chemical
Reg. No./Substance:
0/Phosphodiesterase Inhibitors; 0/Piperazines; 0/Purines; 0/Sulfones; 139755-83-2/sildenafil; 58-00-4/Apomorphine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum leptin concentration and left ventricular hypertrophy and function in maintenance hemodialysis...
Next Document:  An attempt to improve standardization of sperm motility class assessment using the superimposed imag...